onr:"swepub:oai:prod.swepub.kib.ki.se:149293362"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:149293362" > Holy Grail: the jou...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Busse, WW (author)
Holy Grail: the journey towards disease modification in asthma
- Article/chapterEnglish2022
Publisher, publication year, extent ...
- 2022-02-22
- European Respiratory Society (ERS),2022
Numbers
- LIBRIS-ID:oai:prod.swepub.kib.ki.se:149293362
- http://kipublications.ki.se/Default.aspx?queryparsed=id:149293362URI
- https://doi.org/10.1183/16000617.0183-2021DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- At present, there is no cure for asthma, and treatment typically involves therapies that prevent or reduce asthma symptoms, without modifying the underlying disease. A “disease-modifying” treatment can be classed as able to address the pathogenesis of a disease, preventing progression or leading to a long-term reduction in symptoms. Such therapies have been investigated and approved in other indications, e.g. rheumatoid arthritis and immunoglobulin E-mediated allergic disease. Asthma's heterogeneous nature has made the discovery of similar therapies in asthma more difficult, although novel therapies (e.g. biologics) may have the potential to exhibit disease-modifying properties. To investigate the disease-modifying potential of a treatment, study design considerations can be made, including: appropriate end-point selection, length of trial, age of study population (key differences between adults/children in physiology, pathology and drug metabolism) and comorbidities in the patient population. Potential future focus areas for disease-modifying treatments in asthma include early assessments (e.g. to detect patterns of remodelling) and interventions for patients genetically susceptible to asthma, interventions to prevent virally induced asthma and therapies to promote a healthy microbiome. This review explores the pathophysiology of asthma, the disease-modifying potential of current asthma therapies and the direction future research may take to achieve full disease remission or prevention.
Added entries (persons, corporate bodies, meetings, titles ...)
- Melen, EKarolinska Institutet (author)
- Menzies-Gow, AN (author)
- Karolinska Institutet (creator_code:org_t)
Related titles
- In:European respiratory review : an official journal of the European Respiratory Society: European Respiratory Society (ERS)31:1631600-0617
- In:European Respiratory Review: European Respiratory Society (ERS)31:1630905-9180
Internet link
Find in a library
- European respiratory review : an official journal of the European Respiratory So... (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Busse, WW
- Melen, E
- Menzies-Gow, AN
- Articles in the publication
- European respira ...
- European Respira ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
